Literature DB >> 19741007

Regulation of serotonin 1B receptor by glycogen synthase kinase-3.

Ligong Chen1, Gregory D Salinas, Xiaohua Li.   

Abstract

In response to 5-hydroxytryptamine (5-HT), the type 1 serotonin receptors (5-HT1Rs) preferentially couple to the inhibitory G protein and elicit many physiological and behavioral processes. However, their regulation by intracellular protein kinases has not been fully investigated. In this study, we identified that glycogen synthase kinase-3 (GSK3) differentially regulates 5-HT1Rs. In receptor-expressing cells and brain slices, activation of both 5-HT1AR and 5-HT1BR reduced forskolin-stimulated cAMP production, but only the effect of 5-HT1BR was abolished by selective GSK3 inhibitors, deletion of GSK3beta by RNAi, or overexpression of impaired GSK3beta mutants (R96A and K85,86A). A consensus GSK3 phosphorylation sequence was identified between the serine-154 and threonine-158 in the second intracellular loop of 5-HT1BR. Mutation of either serine-154 or threonine-158 to alanine significantly reduced response of 5-HT1BR to 5-HT. Active GSK3beta interacted with resting 5-HT1BR to form a protein complex. The interaction was enhanced by receptor activation, abolished by GSK3 inhibitors, and dependent on the phosphorylation state of serine-154. In addition, regulation of 5-HT1BR by GSK3 changed the dynamics of agonist-induced cell surface receptor internalization, in which lack of phosphorylation at Ser154 resulted in sustained reduction of 5-HT1BR at the cell surface. Although the physiological consequences of selective regulation of 5-HT1BR by GSK3 remain to be identified, findings in this study reveal a new function of GSK3 as a protein kinase that is able to selectively regulate G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741007      PMCID: PMC2784733          DOI: 10.1124/mol.109.056994

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

Authors:  S Frame; P Cohen; R M Biondi
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 3.  The glamour and gloom of glycogen synthase kinase-3.

Authors:  Richard S Jope; Gail V W Johnson
Journal:  Trends Biochem Sci       Date:  2004-02       Impact factor: 13.807

4.  Activation of Akt1 by human 5-hydroxytryptamine (serotonin)1B receptors is sensitive to inhibitors of MEK.

Authors:  E H Hsu; A C Lochan; D S Cowen
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

5.  Interaction of lithium with 5-HT(1B) receptors in depressed unipolar patients treated with clomipramine and lithium versus clomipramine and placebo: preliminary results.

Authors:  Dominique Januel; Olivier Massot; Marie-France Poirier; Jean-Pierre Olié; Gilles Fillion
Journal:  Psychiatry Res       Date:  2002-08-30       Impact factor: 3.222

6.  Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

Authors:  Fang Zhang; Christopher J Phiel; Laura Spece; Nadia Gurvich; Peter S Klein
Journal:  J Biol Chem       Date:  2003-06-07       Impact factor: 5.157

Review 7.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

8.  Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.

Authors:  John A Gray; Beth A Compton-Toth; Bryan L Roth
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

9.  Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C.

Authors:  Justin H Turner; Andrew K Gelasco; John R Raymond
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

10.  Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

Authors:  Patrizia De Sarno; Xiaohua Li; Richard S Jope
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  23 in total

1.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment.

Authors:  Xiaohong Li; Min Liu; Zhuoji Cai; Gang Wang; Xiaohua Li
Journal:  Bipolar Disord       Date:  2010-11       Impact factor: 6.744

Review 2.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 3.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

4.  Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.

Authors:  Alan P Kozikowski; Hendra Gunosewoyo; Songpo Guo; Irina N Gaisina; Richard L Walter; Ariel Ketcherside; Colleen A McClung; Andrew D Mesecar; Barbara Caldarone
Journal:  ChemMedChem       Date:  2011-07-05       Impact factor: 3.466

5.  A noncanonical postsynaptic transport route for a GPCR belonging to the serotonin receptor family.

Authors:  Thomas Liebmann; Markus Kruusmägi; Nermin Sourial-Bassillious; Alexander Bondar; Per Svenningsson; Marc Flajolet; Paul Greengard; Lena Scott; Hjalmar Brismar; Anita Aperia
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

6.  Functional significance of glycogen synthase kinase-3 regulation by serotonin.

Authors:  Abigail M Polter; Sufen Yang; Richard S Jope; Xiaohua Li
Journal:  Cell Signal       Date:  2011-09-17       Impact factor: 4.315

7.  5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins.

Authors:  Yusha Liu; Alec W Gibson; Marjorie R Levinstein; Atom J Lesiak; Shao-En Ong; John F Neumaier
Journal:  ACS Chem Neurosci       Date:  2019-04-29       Impact factor: 4.418

8.  Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway.

Authors:  Kashif Aziz Khan; Florence Dô; Alexandre Marineau; Priscilla Doyon; Jean-François Clément; James R Woodgett; Bradley W Doble; Marc J Servant
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

Review 9.  Glycogen synthase kinase-3 signaling in cellular and behavioral responses to psychostimulant drugs.

Authors:  Jeffrey L Barr; Ellen M Unterwald
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-05-23       Impact factor: 4.739

10.  Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells.

Authors:  Marika Heblinski; Christopher Bladen; Mark Connor
Journal:  Br J Pharmacol       Date:  2018-12-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.